Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × edoxaban × 30 days × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thromboembolism 1 Neoplasms 1 Embolism 1

Interventions

pembrolizumab 22 Cyclophosphamide 14 Carboplatin 10 Bevacizumab 9 Paclitaxel 8 Doxorubicin 8 Pemetrexed 7 Nivolumab 7 durvalumab 6 atezolizumab 6 Rituximab 6 Fulvestrant 6 fludarabine 5 Trastuzumab 5 Standard of Care 5 Prednisone 5 Interviews as Topic 5 Focus Groups 5 Fluorouracil 5 Dexamethasone 5 Cisplatin 5 Cetuximab 5 Blood Specimen Collection 5 pertuzumab 4 olaparib 4 Radiotherapy 4 Leucovorin 4 Gemcitabine 4 Biopsy 4 venetoclax 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04618913 2026-03-12

VICTORIE

Pfizer

Active not recruiting

Classical hematology

Embolism, Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡